Participants 129 228 4
patients with non-small-cell lung cancer after failure of first-line chemotherapy: GFPC 10.02 study
Participants 351 399 4
patients with non-small-cell lung cancer (NSCLC)
Participants 1291 1385 6
147 patients were randomized (median age: 60Â±8 years, PS 0/1/2: 44/83/20 patients; males: 78%
